Rocki
ROCKi is a laboratory equipment product from Merck Group. It is a device designed for the purpose of carrying out rock identification and analysis. The core function of ROCKi is to facilitate the examination and characterization of rock samples.
Lab products found in correlation
6 protocols using rocki
Endothelial Cell Transplantation for Corneal Regeneration
Differentiation of hESCs into Embryoid Bodies
Lentiviral Transduction of Pancreatic Organoids
Large-scale 3D Suspension Culture of Undifferentiated hESCs
(Cellspin; Integra Biosciences AG, Switzerland) at a 40rpm agitation rate. For large-scale
expansion, a 100-ml working volume was used as previously described (29 (link)). Briefly,
undifferentiated RH6 cells were cultured with the optimal starting concentration of
2−3×105 cells/mL at the hESC media, which was conditioned by MEFs, fresh 10
mM Rhoassociated kinase inhibitor (ROCKi; Sigma, Netherlands) and 100 ng/mL bFGF. The
spinner flask was placed on a magnetic stir plate in an incubator at 37˚C and 5%
CO2 without changing media during the first two days. RH6 cells were expanded
in a 3D-dynamic suspension culture after 4 days.
Expansion of Human Embryonic Stem Cells as Spheroids
cultured and expanded as spheroids according to a
previously described protocol (22 (link)). Briefly, 2×105
viable cells/ml were cultured in hESC medium that
consisted of Dulbecco’s Modified Eagle Medium/
Ham’s F-12 (DMEM/F12, Gibco, USA) supplemented
with 20% knockout serum replacement (KOSR, Gibco,
USA), 1% insulin-transferrin-selenite (Gibco, USA),
1% nonessential amino-acids (NEAA, Gibco, USA),
1% penicillin/streptomycin (Gibco, USA), 0.1 mM
ß-mercaptoethanol (Sigma-Aldrich, USA), and 100 ng/
ml basic fibroblast growth factor (bFGF, Royan Biotech,
Iran) in non-adhesive bacterial plates. The medium was
renewed every 2 days. When spheroids reached 200-250
µm, they were dissociated into single cells with Accutase
solution (Sigma-Aldrich, USA), and replated on new
bacterial plates at a 1:3 ratio. Cells were treated with 10
µM of ROCK inhibitor (ROCKi, Sigma-Aldrich, USA)
for the first 2 days.
Pancreatic Organoid Lentiviral Transduction
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!